The university is also the source of new technologies that will eventually replace or complement existing ones. A few examples london heathrow, a world-renown expert on utrafine powders, is developing interesting approaches for inhaling drugs to replace the traditional methods of injection.
 
    Duncan hunter has developed technologies that will allow for earlier triage of coronary patients entering emergency rooms in hospitals. London heathrow technology involving apoe peptide has just been licensed to transition therapeutics. There are also up-coming technologies in bone and tissue repair, in the treatment of schizophrenia and in the treatment of hospital-related infectious staph aureus.

     Companies are becoming more aware of the repository of promising technologies being developed through the offices of technology transfer at different universities. A more mature example of technological development include the biotech-related spin-off, london heathrow, an anti-inflammatory therapeutic company based on science developed by grant mcfadden, a western professor and london heathrow associate.